Cervical Cancer

 

National Cervical Screening Program Clinical Guidelines: Important changes for women at intermediate risk:

In light of new evidence, changes to the NCSP's Guidelines for the clinical management of women at intermediate risk will come into effect from 1 February 2021. This follows the Cancer Council Australia Clinical Guidelines review of national data from the renewed program. 

It is now recommended that women with a 12-month follow up HPV (not-16/18) result with LBC prediction negative, pLSIL or LSIL (intermediate risk result) should be recommended to undertake a further HPV follow up test in 12 months' time following their previous HPV test instead of referral to colposcopy. 

Further information about the changes and the revised cervical screening pathway flowchart is now on the NCSP website

Changes to the clinical management of women at intermediate risk - frequently asked questions.

 

COVID-19 Update from the National Cervical Cancer Screening Program:

The National Cervical Screening Program is encouraging healthcare providers to continue to offer routine screening and follow up, understanding that patients may be feeling uncomfortable about attending for screening and healthcare providers/clinics have different capacities and arrangements for managing their patients.

To support your patients during this time, please refer to:

This guidance is supported by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and the Australian Society for Colposcopy and Cervical Pathology.  

Future updates will be provided on the Department of Health Cancer Screening website.

If you or your staff have any further queries, please email cancerscreening@health.gov.au.

 

 

Cervical Cancer Screening Program Officer
Lauren Walker | l.walker@cesphn.com.au

 

Cervical cancer is almost entirely preventable – but screening is vital. Around 80 per cent of Australian women who develop cervical cancer do not get screened regularly as recommended, or have never been screened.

From 1 December 2017, women in Australia are benefiting from a new and more effective screening test for cervical cancer — it’s more accurate and requires testing less often.

 

Resources for health professionals ( including guidelines,template links)  
  • The National Cervical Screening Program Guidelines for 1 December 2017 onwards, can now be accessed at the Cancer Council Australia website.

  • Education and Training courses for GPs and practice nurses can be found at Family Planning NSW.

  • The Pathology Test Guide for Cervical and Vaginal testing provides context for using the variations of cervical screening and shows what to write on the pathology request form on the Dept of Health website.

  • Understanding the National Cervical Screening Program Management Pathway: a guide for health professionals is also a useful reference to help ensure the correct test is requested from the Dept of Health website.

  • A comprehensive summary of information about the Renewal of the National Cervical Screening Program, resources for patients and where to go for more details can be found at the Cancer Institute NSW 

  • GP Fact Sheet: The Cervical Screening Test for Pregnant Women 
  •  

    CESPHN can work with practices to ensure female patients are screened through:

    • Support to implement recall and reminder systems
    • Support to ientify patients due and overdue for screening
    • Support to implement recall and reminder systemes
    • Provision of appropriate resources

     

    Information for health professionals to give to consumers 

    Cervical Screening During Pregnancy Resources 

    For hard copies of these resources, contact the South Eastern Sydney LHD Women's Health Team